| A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma AV Krauze, SD Myrehaug, MG Chang, DJ Holdford, S Smith, J Shih, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 986-992, 2015 | 206 | 2015 |
| AACR LA Philadelphia Cancer Res 76 (14 Suppl), 3-3, 2016 | 182 | 2016 |
| Bringing the heavy: carbon ion therapy in the radiobiological and clinical context CD Schlaff, A Krauze, A Belard, JJ O’Connell, KA Camphausen Radiation oncology 9, 1-19, 2014 | 159 | 2014 |
| Automated glioma grading on conventional MRI images using deep convolutional neural networks Y Zhuge, H Ning, P Mathen, JY Cheng, AV Krauze, K Camphausen, ... Medical physics 47 (7), 3044-3053, 2020 | 129 | 2020 |
| Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas XQ Lun, DL Senger, T Alain, A Oprea, K Parato, D Stojdl, B Lichty, ... Journal of the National Cancer Institute 98 (21), 1546-1557, 2006 | 117 | 2006 |
| A prospective study on 18F-DCFPyL PSMA PET/CT imaging in biochemical recurrence of prostate cancer E Rousseau, D Wilson, F Lacroix-Poisson, A Krauze, K Chi, M Gleave, ... Journal of Nuclear Medicine 60 (11), 1587-1593, 2019 | 104 | 2019 |
| Brain tumor segmentation using holistically nested neural networks in MRI images Y Zhuge, AV Krauze, H Ning, JY Cheng, BC Arora, K Camphausen, ... Medical physics 44 (10), 5234-5243, 2017 | 98 | 2017 |
| A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study HI Robins, P Zhang, MR Gilbert, A Chakravarti, JF de Groot, SA Grimm, ... Journal of neuro-oncology 126, 309-316, 2016 | 64 | 2016 |
| Bias and class imbalance in oncologic data—towards inclusive and transferrable AI in large scale oncology data sets E Tasci, Y Zhuge, K Camphausen, AV Krauze Cancers 14 (12), 2897, 2022 | 52 | 2022 |
| Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM LS Rowe, JA Butman, M Mackey, JH Shih, T Cooley-Zgela, H Ning, ... Journal of neuro-oncology 139, 145-152, 2018 | 41 | 2018 |
| Expert consensus on re-irradiation for recurrent glioma AV Krauze, A Attia, S Braunstein, M Chan, SE Combs, R Fietkau, ... Radiation Oncology 12, 1-10, 2017 | 36 | 2017 |
| ACTR-58. Phase III trial of CCNU/Temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT-METHYLATED glioblastoma patients: the CeTeg/NOA-09 trial U Herrlinger, T Tzaridis, F Mack, J Steinbach, U Schlegel, M Sabel, P Hau, ... Neuro-oncology 19 (suppl_6), vi13-vi14, 2017 | 32 | 2017 |
| Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy LF Valle, MD Greer, JH Shih, T Barrett, YM Law, AB Rosenkrantz, ... Diagnostic and Interventional Radiology 24 (1), 46, 2018 | 27 | 2018 |
| Chemoirradiation for glioblastoma multiforme: the national cancer institute experience J Ho, J Ondos, H Ning, S Smith, T Kreisl, F Iwamoto, J Sul, L Kim, ... PloS one 8 (8), e70745, 2013 | 24 | 2013 |
| Re-irradiation for recurrent glioma-the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system AV Krauze, C Peters, J Cheng, H Ning, M Mackey, L Rowe, ... Radiation Oncology 12, 1-10, 2017 | 21 | 2017 |
| Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal … F Bénard, S Harsini, D Wilson, K Zukotynski, G Abikhzer, E Turcotte, ... The Lancet Oncology 23 (12), 1499-1507, 2022 | 19 | 2022 |
| Hierarchical Voting-Based Feature Selection and Ensemble Learning Model Scheme for Glioma Grading with Clinical and Molecular Characteristics E Tasci, Y Zhuge, H Kaur, K Camphausen, AV Krauze International Journal of Molecular Sciences 23 (22), 14155, 2022 | 19 | 2022 |
| Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma AV Krauze, M Mackey, L Rowe, MG Chang, DJ Holdford, T Cooley, J Shih, ... Neuro-Oncology Practice 5 (4), 246-250, 2018 | 16 | 2018 |
| The evolving role for re-irradiation in the management of recurrent grade 4 glioma SP Howard, A Krauze, MD Chan, C Tsien, WA Tomé Journal of neuro-oncology 134, 523-530, 2017 | 16 | 2017 |
| Survival prediction in gliomas: current state and novel approaches R Zhao, A Krauze Exon Publications, 151-169, 2021 | 15 | 2021 |
